IPCA LABORATORIES
Back to Balance Sheet
|
IPCA LABORATORIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹2,384 Cr | ₹2,356 Cr | ₹1,806 Cr | ₹1,466 Cr | ₹1,161 Cr |
What is the latest Total Current Liabilities ratio of IPCA LABORATORIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹2,384 Cr |
| Mar2024 | ₹2,356 Cr |
| Mar2023 | ₹1,806 Cr |
| Mar2022 | ₹1,466 Cr |
| Mar2021 | ₹1,161 Cr |
How is Total Current Liabilities of IPCA LABORATORIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹2,384 Cr | 1.22 | |
| Mar2024 | ₹2,356 Cr | 30.45 | |
| Mar2023 | ₹1,806 Cr | 23.19 | |
| Mar2022 | ₹1,466 Cr | 26.31 | |
| Mar2021 | ₹1,161 Cr | - | |
Compare Total Current Liabilities of peers of IPCA LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| IPCA LABORATORIES | ₹37,221.6 Cr | 1.2% | 12.6% | -4.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹430,513.0 Cr | -0.1% | 3.4% | -0.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹170,614.0 Cr | 1.6% | -2.5% | 8.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹128,245.0 Cr | 0.8% | -0.9% | 13.5% | Stock Analytics | |
| CIPLA | ₹122,555.0 Cr | 1.3% | -0.6% | 3.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹106,803.0 Cr | 1% | 3.7% | 2.7% | Stock Analytics | |
IPCA LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| IPCA LABORATORIES | 1.2% |
12.6% |
-4.1% |
| SENSEX | -0.5% |
1% |
4.6% |
You may also like the below Video Courses